Global Invasive Candidiasis Treatment Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Invasive Candidiasis Treatment Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Invasive Candidiasis Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Invasive Candidiasis Treatment Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Invasive Candidiasis Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Invasive Candidiasis Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Invasive Candidiasis Treatment Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Invasive Candidiasis Treatment Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Invasive Candidiasis Treatment Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc and Astellas Pharma Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Invasive Candidiasis Treatment Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Invasive Candidiasis Treatment Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Invasive Candidiasis Treatment Drug, with revenue, gross margin and global market share of Invasive Candidiasis Treatment Drug from 2018 to 2023.
Chapter 3, the Invasive Candidiasis Treatment Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Invasive Candidiasis Treatment Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Invasive Candidiasis Treatment Drug.
Chapter 13, to describe Invasive Candidiasis Treatment Drug research findings and conclusion.
This report is a detailed and comprehensive analysis for global Invasive Candidiasis Treatment Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Invasive Candidiasis Treatment Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Invasive Candidiasis Treatment Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Invasive Candidiasis Treatment Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Invasive Candidiasis Treatment Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Invasive Candidiasis Treatment Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Invasive Candidiasis Treatment Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Merck & Co., Inc, Pfizer Inc, Cidara Therapeutics, Inc and Astellas Pharma Inc, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Invasive Candidiasis Treatment Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Azoles Drug
- Echinocandins Drug
- Allylamines Drug
- Polyenes Drug
- Others
- Hospital
- Clinic
- Others
- GlaxoSmithKline
- Merck & Co., Inc
- Pfizer Inc
- Cidara Therapeutics, Inc
- Astellas Pharma Inc
- Gilead Sciences, Inc
- Novo Nordisk A/S (Xellia Pharmaceuticals)
- Biosergen AB
- Matinas BioPharma Holdings, Inc
- Pulmocide Ltd
- F2G Ltd
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Invasive Candidiasis Treatment Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Invasive Candidiasis Treatment Drug, with revenue, gross margin and global market share of Invasive Candidiasis Treatment Drug from 2018 to 2023.
Chapter 3, the Invasive Candidiasis Treatment Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Invasive Candidiasis Treatment Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Invasive Candidiasis Treatment Drug.
Chapter 13, to describe Invasive Candidiasis Treatment Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Invasive Candidiasis Treatment Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Invasive Candidiasis Treatment Drug by Type
1.3.1 Overview: Global Invasive Candidiasis Treatment Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type in 2022
1.3.3 Azoles Drug
1.3.4 Echinocandins Drug
1.3.5 Allylamines Drug
1.3.6 Polyenes Drug
1.3.7 Others
1.4 Global Invasive Candidiasis Treatment Drug Market by Application
1.4.1 Overview: Global Invasive Candidiasis Treatment Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Invasive Candidiasis Treatment Drug Market Size & Forecast
1.6 Global Invasive Candidiasis Treatment Drug Market Size and Forecast by Region
1.6.1 Global Invasive Candidiasis Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Invasive Candidiasis Treatment Drug Market Size by Region, (2018-2029)
1.6.3 North America Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.6 South America Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Solutions
2.1.4 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.2.4 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co., Inc Recent Developments and Future Plans
2.3 Pfizer Inc
2.3.1 Pfizer Inc Details
2.3.2 Pfizer Inc Major Business
2.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.3.4 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Inc Recent Developments and Future Plans
2.4 Cidara Therapeutics, Inc
2.4.1 Cidara Therapeutics, Inc Details
2.4.2 Cidara Therapeutics, Inc Major Business
2.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.4.4 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cidara Therapeutics, Inc Recent Developments and Future Plans
2.5 Astellas Pharma Inc
2.5.1 Astellas Pharma Inc Details
2.5.2 Astellas Pharma Inc Major Business
2.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.5.4 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Astellas Pharma Inc Recent Developments and Future Plans
2.6 Gilead Sciences, Inc
2.6.1 Gilead Sciences, Inc Details
2.6.2 Gilead Sciences, Inc Major Business
2.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.6.4 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
2.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Details
2.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
2.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Solutions
2.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments and Future Plans
2.8 Biosergen AB
2.8.1 Biosergen AB Details
2.8.2 Biosergen AB Major Business
2.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product and Solutions
2.8.4 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biosergen AB Recent Developments and Future Plans
2.9 Matinas BioPharma Holdings, Inc
2.9.1 Matinas BioPharma Holdings, Inc Details
2.9.2 Matinas BioPharma Holdings, Inc Major Business
2.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.9.4 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Matinas BioPharma Holdings, Inc Recent Developments and Future Plans
2.10 Pulmocide Ltd
2.10.1 Pulmocide Ltd Details
2.10.2 Pulmocide Ltd Major Business
2.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Solutions
2.10.4 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pulmocide Ltd Recent Developments and Future Plans
2.11 F2G Ltd
2.11.1 F2G Ltd Details
2.11.2 F2G Ltd Major Business
2.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product and Solutions
2.11.4 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 F2G Ltd Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Invasive Candidiasis Treatment Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Invasive Candidiasis Treatment Drug by Company Revenue
3.2.2 Top 3 Invasive Candidiasis Treatment Drug Players Market Share in 2022
3.2.3 Top 6 Invasive Candidiasis Treatment Drug Players Market Share in 2022
3.3 Invasive Candidiasis Treatment Drug Market: Overall Company Footprint Analysis
3.3.1 Invasive Candidiasis Treatment Drug Market: Region Footprint
3.3.2 Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
3.3.3 Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Invasive Candidiasis Treatment Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
6.2 North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
6.3 North America Invasive Candidiasis Treatment Drug Market Size by Country
6.3.1 North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
6.3.2 United States Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
7.2 Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Country
7.3.1 Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.3 France Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region
8.3.1 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2029)
8.3.2 China Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.5 India Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
9.2 South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
9.3 South America Invasive Candidiasis Treatment Drug Market Size by Country
9.3.1 South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country
10.3.1 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Invasive Candidiasis Treatment Drug Market Drivers
11.2 Invasive Candidiasis Treatment Drug Market Restraints
11.3 Invasive Candidiasis Treatment Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Invasive Candidiasis Treatment Drug Industry Chain
12.2 Invasive Candidiasis Treatment Drug Upstream Analysis
12.3 Invasive Candidiasis Treatment Drug Midstream Analysis
12.4 Invasive Candidiasis Treatment Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Invasive Candidiasis Treatment Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Invasive Candidiasis Treatment Drug by Type
1.3.1 Overview: Global Invasive Candidiasis Treatment Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type in 2022
1.3.3 Azoles Drug
1.3.4 Echinocandins Drug
1.3.5 Allylamines Drug
1.3.6 Polyenes Drug
1.3.7 Others
1.4 Global Invasive Candidiasis Treatment Drug Market by Application
1.4.1 Overview: Global Invasive Candidiasis Treatment Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Invasive Candidiasis Treatment Drug Market Size & Forecast
1.6 Global Invasive Candidiasis Treatment Drug Market Size and Forecast by Region
1.6.1 Global Invasive Candidiasis Treatment Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Invasive Candidiasis Treatment Drug Market Size by Region, (2018-2029)
1.6.3 North America Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.6 South America Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Invasive Candidiasis Treatment Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Solutions
2.1.4 GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GlaxoSmithKline Recent Developments and Future Plans
2.2 Merck & Co., Inc
2.2.1 Merck & Co., Inc Details
2.2.2 Merck & Co., Inc Major Business
2.2.3 Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.2.4 Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Merck & Co., Inc Recent Developments and Future Plans
2.3 Pfizer Inc
2.3.1 Pfizer Inc Details
2.3.2 Pfizer Inc Major Business
2.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.3.4 Pfizer Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Pfizer Inc Recent Developments and Future Plans
2.4 Cidara Therapeutics, Inc
2.4.1 Cidara Therapeutics, Inc Details
2.4.2 Cidara Therapeutics, Inc Major Business
2.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.4.4 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Cidara Therapeutics, Inc Recent Developments and Future Plans
2.5 Astellas Pharma Inc
2.5.1 Astellas Pharma Inc Details
2.5.2 Astellas Pharma Inc Major Business
2.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.5.4 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Astellas Pharma Inc Recent Developments and Future Plans
2.6 Gilead Sciences, Inc
2.6.1 Gilead Sciences, Inc Details
2.6.2 Gilead Sciences, Inc Major Business
2.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.6.4 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Gilead Sciences, Inc Recent Developments and Future Plans
2.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
2.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Details
2.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
2.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Solutions
2.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments and Future Plans
2.8 Biosergen AB
2.8.1 Biosergen AB Details
2.8.2 Biosergen AB Major Business
2.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product and Solutions
2.8.4 Biosergen AB Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Biosergen AB Recent Developments and Future Plans
2.9 Matinas BioPharma Holdings, Inc
2.9.1 Matinas BioPharma Holdings, Inc Details
2.9.2 Matinas BioPharma Holdings, Inc Major Business
2.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Solutions
2.9.4 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Matinas BioPharma Holdings, Inc Recent Developments and Future Plans
2.10 Pulmocide Ltd
2.10.1 Pulmocide Ltd Details
2.10.2 Pulmocide Ltd Major Business
2.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Solutions
2.10.4 Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Pulmocide Ltd Recent Developments and Future Plans
2.11 F2G Ltd
2.11.1 F2G Ltd Details
2.11.2 F2G Ltd Major Business
2.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product and Solutions
2.11.4 F2G Ltd Invasive Candidiasis Treatment Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 F2G Ltd Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Invasive Candidiasis Treatment Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Invasive Candidiasis Treatment Drug by Company Revenue
3.2.2 Top 3 Invasive Candidiasis Treatment Drug Players Market Share in 2022
3.2.3 Top 6 Invasive Candidiasis Treatment Drug Players Market Share in 2022
3.3 Invasive Candidiasis Treatment Drug Market: Overall Company Footprint Analysis
3.3.1 Invasive Candidiasis Treatment Drug Market: Region Footprint
3.3.2 Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
3.3.3 Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Invasive Candidiasis Treatment Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
6.2 North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
6.3 North America Invasive Candidiasis Treatment Drug Market Size by Country
6.3.1 North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
6.3.2 United States Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
7.2 Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
7.3 Europe Invasive Candidiasis Treatment Drug Market Size by Country
7.3.1 Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.3 France Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Invasive Candidiasis Treatment Drug Market Size by Region
8.3.1 Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2029)
8.3.2 China Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.5 India Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
9.2 South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
9.3 South America Invasive Candidiasis Treatment Drug Market Size by Country
9.3.1 South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Invasive Candidiasis Treatment Drug Market Size by Country
10.3.1 Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Invasive Candidiasis Treatment Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Invasive Candidiasis Treatment Drug Market Drivers
11.2 Invasive Candidiasis Treatment Drug Market Restraints
11.3 Invasive Candidiasis Treatment Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Invasive Candidiasis Treatment Drug Industry Chain
12.2 Invasive Candidiasis Treatment Drug Upstream Analysis
12.3 Invasive Candidiasis Treatment Drug Midstream Analysis
12.4 Invasive Candidiasis Treatment Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Invasive Candidiasis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Invasive Candidiasis Treatment Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Invasive Candidiasis Treatment Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 6. GlaxoSmithKline Major Business
Table 7. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Solutions
Table 8. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GlaxoSmithKline Recent Developments and Future Plans
Table 10. Merck & Co., Inc Company Information, Head Office, and Major Competitors
Table 11. Merck & Co., Inc Major Business
Table 12. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 13. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck & Co., Inc Recent Developments and Future Plans
Table 15. Pfizer Inc Company Information, Head Office, and Major Competitors
Table 16. Pfizer Inc Major Business
Table 17. Pfizer Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 18. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Pfizer Inc Recent Developments and Future Plans
Table 20. Cidara Therapeutics, Inc Company Information, Head Office, and Major Competitors
Table 21. Cidara Therapeutics, Inc Major Business
Table 22. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 23. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cidara Therapeutics, Inc Recent Developments and Future Plans
Table 25. Astellas Pharma Inc Company Information, Head Office, and Major Competitors
Table 26. Astellas Pharma Inc Major Business
Table 27. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 28. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Astellas Pharma Inc Recent Developments and Future Plans
Table 30. Gilead Sciences, Inc Company Information, Head Office, and Major Competitors
Table 31. Gilead Sciences, Inc Major Business
Table 32. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 33. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Gilead Sciences, Inc Recent Developments and Future Plans
Table 35. Novo Nordisk A/S (Xellia Pharmaceuticals) Company Information, Head Office, and Major Competitors
Table 36. Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
Table 37. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Solutions
Table 38. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments and Future Plans
Table 40. Biosergen AB Company Information, Head Office, and Major Competitors
Table 41. Biosergen AB Major Business
Table 42. Biosergen AB Invasive Candidiasis Treatment Drug Product and Solutions
Table 43. Biosergen AB Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Biosergen AB Recent Developments and Future Plans
Table 45. Matinas BioPharma Holdings, Inc Company Information, Head Office, and Major Competitors
Table 46. Matinas BioPharma Holdings, Inc Major Business
Table 47. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 48. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Matinas BioPharma Holdings, Inc Recent Developments and Future Plans
Table 50. Pulmocide Ltd Company Information, Head Office, and Major Competitors
Table 51. Pulmocide Ltd Major Business
Table 52. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Solutions
Table 53. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pulmocide Ltd Recent Developments and Future Plans
Table 55. F2G Ltd Company Information, Head Office, and Major Competitors
Table 56. F2G Ltd Major Business
Table 57. F2G Ltd Invasive Candidiasis Treatment Drug Product and Solutions
Table 58. F2G Ltd Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. F2G Ltd Recent Developments and Future Plans
Table 60. Global Invasive Candidiasis Treatment Drug Revenue (USD Million) by Players (2018-2023)
Table 61. Global Invasive Candidiasis Treatment Drug Revenue Share by Players (2018-2023)
Table 62. Breakdown of Invasive Candidiasis Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Invasive Candidiasis Treatment Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Invasive Candidiasis Treatment Drug Players
Table 65. Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
Table 66. Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
Table 67. Invasive Candidiasis Treatment Drug New Market Entrants and Barriers to Market Entry
Table 68. Invasive Candidiasis Treatment Drug Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Invasive Candidiasis Treatment Drug Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Invasive Candidiasis Treatment Drug Consumption Value Share by Type (2018-2023)
Table 71. Global Invasive Candidiasis Treatment Drug Consumption Value Forecast by Type (2024-2029)
Table 72. Global Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023)
Table 73. Global Invasive Candidiasis Treatment Drug Consumption Value Forecast by Application (2024-2029)
Table 74. North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Invasive Candidiasis Treatment Drug Raw Material
Table 105. Key Suppliers of Invasive Candidiasis Treatment Drug Raw Materials
Table 1. Global Invasive Candidiasis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Invasive Candidiasis Treatment Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Invasive Candidiasis Treatment Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 6. GlaxoSmithKline Major Business
Table 7. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product and Solutions
Table 8. GlaxoSmithKline Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GlaxoSmithKline Recent Developments and Future Plans
Table 10. Merck & Co., Inc Company Information, Head Office, and Major Competitors
Table 11. Merck & Co., Inc Major Business
Table 12. Merck & Co., Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 13. Merck & Co., Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Merck & Co., Inc Recent Developments and Future Plans
Table 15. Pfizer Inc Company Information, Head Office, and Major Competitors
Table 16. Pfizer Inc Major Business
Table 17. Pfizer Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 18. Pfizer Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Pfizer Inc Recent Developments and Future Plans
Table 20. Cidara Therapeutics, Inc Company Information, Head Office, and Major Competitors
Table 21. Cidara Therapeutics, Inc Major Business
Table 22. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 23. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Cidara Therapeutics, Inc Recent Developments and Future Plans
Table 25. Astellas Pharma Inc Company Information, Head Office, and Major Competitors
Table 26. Astellas Pharma Inc Major Business
Table 27. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 28. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Astellas Pharma Inc Recent Developments and Future Plans
Table 30. Gilead Sciences, Inc Company Information, Head Office, and Major Competitors
Table 31. Gilead Sciences, Inc Major Business
Table 32. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 33. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Gilead Sciences, Inc Recent Developments and Future Plans
Table 35. Novo Nordisk A/S (Xellia Pharmaceuticals) Company Information, Head Office, and Major Competitors
Table 36. Novo Nordisk A/S (Xellia Pharmaceuticals) Major Business
Table 37. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product and Solutions
Table 38. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments and Future Plans
Table 40. Biosergen AB Company Information, Head Office, and Major Competitors
Table 41. Biosergen AB Major Business
Table 42. Biosergen AB Invasive Candidiasis Treatment Drug Product and Solutions
Table 43. Biosergen AB Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Biosergen AB Recent Developments and Future Plans
Table 45. Matinas BioPharma Holdings, Inc Company Information, Head Office, and Major Competitors
Table 46. Matinas BioPharma Holdings, Inc Major Business
Table 47. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product and Solutions
Table 48. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Matinas BioPharma Holdings, Inc Recent Developments and Future Plans
Table 50. Pulmocide Ltd Company Information, Head Office, and Major Competitors
Table 51. Pulmocide Ltd Major Business
Table 52. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product and Solutions
Table 53. Pulmocide Ltd Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Pulmocide Ltd Recent Developments and Future Plans
Table 55. F2G Ltd Company Information, Head Office, and Major Competitors
Table 56. F2G Ltd Major Business
Table 57. F2G Ltd Invasive Candidiasis Treatment Drug Product and Solutions
Table 58. F2G Ltd Invasive Candidiasis Treatment Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. F2G Ltd Recent Developments and Future Plans
Table 60. Global Invasive Candidiasis Treatment Drug Revenue (USD Million) by Players (2018-2023)
Table 61. Global Invasive Candidiasis Treatment Drug Revenue Share by Players (2018-2023)
Table 62. Breakdown of Invasive Candidiasis Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Invasive Candidiasis Treatment Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 64. Head Office of Key Invasive Candidiasis Treatment Drug Players
Table 65. Invasive Candidiasis Treatment Drug Market: Company Product Type Footprint
Table 66. Invasive Candidiasis Treatment Drug Market: Company Product Application Footprint
Table 67. Invasive Candidiasis Treatment Drug New Market Entrants and Barriers to Market Entry
Table 68. Invasive Candidiasis Treatment Drug Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Invasive Candidiasis Treatment Drug Consumption Value (USD Million) by Type (2018-2023)
Table 70. Global Invasive Candidiasis Treatment Drug Consumption Value Share by Type (2018-2023)
Table 71. Global Invasive Candidiasis Treatment Drug Consumption Value Forecast by Type (2024-2029)
Table 72. Global Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023)
Table 73. Global Invasive Candidiasis Treatment Drug Consumption Value Forecast by Application (2024-2029)
Table 74. North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 75. North America Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 76. North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 77. North America Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 78. North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 79. North America Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 80. Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Europe Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 83. Europe Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 84. Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 85. Europe Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 86. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 87. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 88. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 89. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 90. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 91. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 92. South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 93. South America Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 94. South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 95. South America Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 96. South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 97. South America Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 99. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 100. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 101. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 102. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 103. Middle East & Africa Invasive Candidiasis Treatment Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 104. Invasive Candidiasis Treatment Drug Raw Material
Table 105. Key Suppliers of Invasive Candidiasis Treatment Drug Raw Materials
LIST OF FIGURES
Figure 1. Invasive Candidiasis Treatment Drug Picture
Figure 2. Global Invasive Candidiasis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type in 2022
Figure 4. Azoles Drug
Figure 5. Echinocandins Drug
Figure 6. Allylamines Drug
Figure 7. Polyenes Drug
Figure 8. Others
Figure 9. Global Invasive Candidiasis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application in 2022
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Others Picture
Figure 14. Global Invasive Candidiasis Treatment Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Invasive Candidiasis Treatment Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Invasive Candidiasis Treatment Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Invasive Candidiasis Treatment Drug Revenue Share by Players in 2022
Figure 25. Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Invasive Candidiasis Treatment Drug Market Share in 2022
Figure 27. Global Top 6 Players Invasive Candidiasis Treatment Drug Market Share in 2022
Figure 28. Global Invasive Candidiasis Treatment Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Invasive Candidiasis Treatment Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Invasive Candidiasis Treatment Drug Market Drivers
Figure 67. Invasive Candidiasis Treatment Drug Market Restraints
Figure 68. Invasive Candidiasis Treatment Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Invasive Candidiasis Treatment Drug in 2022
Figure 71. Manufacturing Process Analysis of Invasive Candidiasis Treatment Drug
Figure 72. Invasive Candidiasis Treatment Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Invasive Candidiasis Treatment Drug Picture
Figure 2. Global Invasive Candidiasis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type in 2022
Figure 4. Azoles Drug
Figure 5. Echinocandins Drug
Figure 6. Allylamines Drug
Figure 7. Polyenes Drug
Figure 8. Others
Figure 9. Global Invasive Candidiasis Treatment Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application in 2022
Figure 11. Hospital Picture
Figure 12. Clinic Picture
Figure 13. Others Picture
Figure 14. Global Invasive Candidiasis Treatment Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Invasive Candidiasis Treatment Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Invasive Candidiasis Treatment Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Invasive Candidiasis Treatment Drug Revenue Share by Players in 2022
Figure 25. Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Invasive Candidiasis Treatment Drug Market Share in 2022
Figure 27. Global Top 6 Players Invasive Candidiasis Treatment Drug Market Share in 2022
Figure 28. Global Invasive Candidiasis Treatment Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Invasive Candidiasis Treatment Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Invasive Candidiasis Treatment Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Invasive Candidiasis Treatment Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Invasive Candidiasis Treatment Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Invasive Candidiasis Treatment Drug Market Drivers
Figure 67. Invasive Candidiasis Treatment Drug Market Restraints
Figure 68. Invasive Candidiasis Treatment Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Invasive Candidiasis Treatment Drug in 2022
Figure 71. Manufacturing Process Analysis of Invasive Candidiasis Treatment Drug
Figure 72. Invasive Candidiasis Treatment Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
